130 related articles for article (PubMed ID: 2544482)
1. Monoclonal antibodies against alpha toxin of Clostridium perfringens.
Sato H; Chiba J; Sato Y
FEMS Microbiol Lett; 1989 May; 50(1-2):173-6. PubMed ID: 2544482
[TBL] [Abstract][Full Text] [Related]
2. Epitope mapping of the alpha-toxin of Clostridium perfringens.
Logan AJ; Williamson ED; Titball RW; Percival DA; Shuttleworth AD; Conlan JW; Kelly DC
Infect Immun; 1991 Dec; 59(12):4338-42. PubMed ID: 1718874
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of hemolytic and mouse lethal activities of C. perfringens alpha-toxin need simultaneous blockade of two epitopes by monoclonal antibodies.
Schoepe H; Wieler LH; Bauerfeind R; Schlapp T; Potschka H; Hehnen HR; Baljer G
Microb Pathog; 1997 Jul; 23(1):1-10. PubMed ID: 9250775
[TBL] [Abstract][Full Text] [Related]
4. Naturally occurring Clostridium perfringens nontoxic alpha-toxin variant as a potential vaccine candidate against alpha-toxin-associated diseases.
Schoepe H; Pache C; Neubauer A; Potschka H; Schlapp T; Wieler LH; Baljer G
Infect Immun; 2001 Nov; 69(11):7194-6. PubMed ID: 11598102
[TBL] [Abstract][Full Text] [Related]
5. Molecular variation between the alpha-toxins from the type strain (NCTC 8237) and clinical isolates of Clostridium perfringens associated with disease in man and animals.
Ginter A; Williamson ED; Dessy F; Coppe P; Bullifent H; Howells A; Titball RW
Microbiology (Reading); 1996 Jan; 142 ( Pt 1)():191-198. PubMed ID: 8581165
[TBL] [Abstract][Full Text] [Related]
6. Detection of Clostridium perfringens alpha toxin by enzyme-linked immunosorbent assay.
Naylor RD; Martin PK; Barker LT
Res Vet Sci; 1997; 63(1):101-2. PubMed ID: 9368967
[TBL] [Abstract][Full Text] [Related]
7. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.
Hauer PJ; Clough NE
Dev Biol Stand; 1999; 101():85-94. PubMed ID: 10566780
[TBL] [Abstract][Full Text] [Related]
8. Measurement of Clostridium perfringens beta-toxin production by surface plasmon resonance immunoassay.
Hsieh HV; Stewart B; Hauer P; Haaland P; Campbell R
Vaccine; 1998; 16(9-10):997-1003. PubMed ID: 9682350
[TBL] [Abstract][Full Text] [Related]
9. On the in vitro neutralization test of Clostridium perfringens type A toxin.
Shemanova GF; Vlasova EV; Postnikova TM
J Hyg Epidemiol Microbiol Immunol; 1988; 32(2):219-26. PubMed ID: 2900852
[TBL] [Abstract][Full Text] [Related]
10. Detection of Clostridium perfringens alpha toxin using a capture antibody ELISA.
Hale ML; Stiles BG
Toxicon; 1999 Mar; 37(3):471-84. PubMed ID: 10080352
[TBL] [Abstract][Full Text] [Related]
11. Recombinant vaccinia viruses protect against Clostridium perfringens alpha-toxin.
Bennett AM; Lescott T; Phillpotts RJ; Mackett M; Titball RW
Viral Immunol; 1999; 12(2):97-105. PubMed ID: 10413356
[TBL] [Abstract][Full Text] [Related]
12. A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene.
Williamson ED; Titball RW
Vaccine; 1993 Sep; 11(12):1253-8. PubMed ID: 8256506
[TBL] [Abstract][Full Text] [Related]
13. A field study of naturally occurring specific antibodies against Clostridium perfringens alpha toxin in Norwegian broiler flocks.
Heier BT; Lovland A; Soleim KB; Kaldhusdal M; Jarp J
Avian Dis; 2001; 45(3):724-32. PubMed ID: 11569751
[TBL] [Abstract][Full Text] [Related]
14. The production and evaluation of monoclonal antibodies to Clostridium perfringens type D epsilon toxin.
Boarer CD; Sojka MG; White VJ; Roeder PL
J Biol Stand; 1988 Jul; 16(3):207-18. PubMed ID: 2902095
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of alpha-toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene.
Awad MM; Ellemor DM; Boyd RL; Emmins JJ; Rood JI
Infect Immun; 2001 Dec; 69(12):7904-10. PubMed ID: 11705975
[TBL] [Abstract][Full Text] [Related]
16. Dissociation of various biological activities of Clostridium perfringens alpha toxin by chemical modification.
Sakurai J; Fujii Y; Torii K; Kobayashi K
Toxicon; 1989; 27(3):317-23. PubMed ID: 2728024
[TBL] [Abstract][Full Text] [Related]
17. Role of the C-domain in the biological activities of Clostridium perfringens alpha-toxin.
Nagahama M; Mukai M; Morimitsu S; Ochi S; Sakurai J
Microbiol Immunol; 2002; 46(10):647-55. PubMed ID: 12477243
[TBL] [Abstract][Full Text] [Related]
18. Purification of alpha toxin from Clostridium perfringens: phospholipase C.
Jolivet-Reynaud C; Moreau H; Alouf JE
Methods Enzymol; 1988; 165():91-4. PubMed ID: 2906730
[No Abstract] [Full Text] [Related]
19. Assay methods for alpha toxin from Clostridium perfringens: phospholipase C.
Jolivet-Reynaud C; Moreau H; Alouf JE
Methods Enzymol; 1988; 165():293-7. PubMed ID: 2906729
[No Abstract] [Full Text] [Related]
20. In vitro aggregation of platelets induced by alpha-toxin (phospholipase C) of Clostridium perfringens.
Sugahara T; Takahashi T; Yamaya S; Ohsaka A
Jpn J Med Sci Biol; 1976 Oct; 29(5):255-63. PubMed ID: 189107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
